| | | | |

Chronic Lyme European PLEASE Trial—You know it’s spin when treatment “success” is called “failure”?

ByTeam

March 30th, 2016

Today a widely anticipated clinical trial on chronic Lyme disease from Europe called PLEASE was published in the New England Journal of Medicine (NEJM).  The press has given the trial a twenty trumpet salute with a MedPage headline reading “Long-Term Antibiotics Fail Again in Lyme Disease–Focus on Lyme and antibiotics for persistent symptoms called unhelpful.”  Here’s the thing—the findings of the study actually support retreatment.  What gives? … read on

Full article

 

Stay safe in the outdoors

Get a tick removal kit

Your support can change lives

Get our news and updates by email

Subscribe

Similar Posts

| |

YOU CAN’T COUNT ON TESTING OF ENGORGED TICKS

ByTeam

A recent study published in the Journal of Ticks and Tick-borne Diseases examined the prevalence of ticks in the Quebec region, along with the frequency of Borrelia burgdorferi (Bb) infection in engorged versus non-engorged ticks. by Daniel J. Cameron, MD MPH Gasmi and colleagues found that you cannot always rely on the testing of engorged…

| | |

Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients

ByTeam

[CanLyme note: Here is a quote from the Lyme Disease Research Foundation at John Hopkins University that furthers our long held concerns about the current two-tier testing model in use Canada-wide having very serious limitations as a diagnostic tool, “Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology…

| | | | | |

New York State Grants Approval for IGeneX’s Newly Developed Tick-Borne Relapsing Fever (TBRF) ImmunoBlot Tests

ByCanLyme Team

[CanLyme Note: New York State has one of the strictest certification and approval processes in North America for laboratory tests.  Canadian medical authorities have done nothing but lie about, criticize and malign Igenex for many years based upon opinion not science, simply because Canadians were turning to Igenex for better testing. Igenex has helped thousands of…

| | | | |

Physicians and patients weigh in on latest poorly designed study that raises the question, “Why?”, and, “Who is driving this spin?”

ByTeam

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease Comment “Persister research needs to account for morphological variability of Lyme The patient population studied was already a group that had shown persistence of disease. These would be “treatment failures” and more difficult cases. Even in this difficult population every group who received 2…

| | |

Repurposing disulfiram (Tetraethylthiuram Disulfide) as a potential drug candidate against Borrelia burgdorferi in vitro and in vivo

ByCanLyme Team

This article is a preprint and has not been certified by peer review – Posted Nov 15th, 2019 ABSTRACT Lyme disease caused by the Borrelia burgdorferi (Bb or B. burgdorferi) is a most common vector-borne, multi-systemic disease in USA. Although, most Lyme disease patients can be cured with a course of antibiotic treatment, a significant percent of…

| |

Video, Penticton, BC – City declares May Lyme Disease awareness month and, mayor and council take the Lyme Sucks Challenge

ByTeam

Council proclaims May as Lyme awareness month, and, “Council sucks limes” for Lyme. For the video of the meeting relating to the proclamation and challenge click below and then go to Lyme Disease Awareness – Lyme Sucks Challenge Watch here